Partnership provides US-based sequencing and scalable consumer genomics infrastructure, including an at-home DNA collection, to deliver PrecisionLife’s personalized wellness reports to US consumers.
LinkGevity CEO Dr. Carina Kern joined other global leaders across biotech, medicine, AI, and consumer health at Milken Institute Global Conference to discuss the next phase of longevity science and healthy aging.
Up to $110 million upfront and success-based milestones collaboration will generate large-scale human cellular perturbation datasets to advance understanding of disease biology.
The Milner Therapeutics Institute has joined the o2h Discovery Platinum Partner Programme, enabling eligible companies within its bio-incubator and wider affiliate network to access specialist drug discovery support through the o2h Kickstarter Award.
The UK’s innovative life sciences sector has called on Government to deliver policy continuity, unlock scale-up investment and improve patient access to new medicines.
KQ Labs, a leading accelerator that has helped early-stage life sciences innovators raise over £230 million, is now accepting applications for its ninth programme
IMU Biosciences announce their new strategic partnership with Waters Biosciences to accelerate the development of IMU’s next-generation AI-powered High Definition (HD) Immunology Platform. The partnership will bring together Waters Biosciences’ advanced flow cytometry and single-cell technologies with IMU's HD analysis and proprietary AI and machine learning analytics to turn complex immune data into insights at scale across discovery, translational, and clinical research applications.
PrecisionLife has launched Biology Matters, a new podcast exploring how advances in biology, genomics, data science, and AI can help address one of healthcare's greatest challenges: chronic disease.
Explore Columbus Global's latest life science report featuring expert into the digital trends shaping the future of Pharma, MedTech and Biotech in 2026 and beyond.
Driven by world-class science and monumental funding, the UK TechBio sector is undergoing a profound paradigm shift – meet the innovative BIA members leading the charge
Drug Discovery 2026 returns to ExCeL London from 14–15 October to celebrate 20 years of collaboration and inclusion. Keynote programme includes presentation from Dr Sam Barrell CBE and panel discussion with Dr Anne Phelan, Dr Jason Mellad, Prof Sir Mene Pangalos and Prof Raghib Ali OBE
